Imperial College London
Portrait Picture

Tom Wong

Faculty of Medicine, National Heart & Lung Institute

Reader in Cardiology
 
 
 
//

Contact

 

+44 (0)20 7351 8619tom.wong

 
 
//

Assistant

 

Dr Vias Markides +44 (0)20 7351 8619

 
//

Location

 

Chelsea WingRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Haldar:2021:10.3310/eme08180,
author = {Haldar, S and Khan, HR and Boyalla, V and Kralj-Hans, I and Jones, S and Lord, J and Onyimadu, O and Sathishkumar, A and Bahrami, T and Clague, J and De, Souza A and Francis, D and Hussain, W and Jarman, J and Jones, DG and Chen, Z and Mediratta, N and Hyde, J and Lewis, M and Mohiaddin, R and Salukhe, T and Murphy, C and Kelly, J and Khattar, R and Toff, WD and Markides, V and McCready, J and Gupta, D and Wong, T},
doi = {10.3310/eme08180},
journal = {Efficacy and Mechanism Evaluation},
pages = {1--122},
title = {Thoracoscopic surgical ablation versus catheter ablation as first-line treatment for long-standing persistent atrial fibrillation: the CASA-AF RCT},
url = {http://dx.doi.org/10.3310/eme08180},
volume = {8},
year = {2021}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - <jats:sec id="abs1-1">                  <jats:title>Background</jats:title>                  <jats:p>Standalone thoracoscopic surgical ablation may be more effective than catheter ablation in patients with long-standing persistent atrial fibrillation.</jats:p>               </jats:sec>               <jats:sec id="abs1-2">                  <jats:title>Objectives</jats:title>                  <jats:p>To determine whether or not surgical ablation is clinically superior to catheter ablation as the first-line treatment strategy in long-standing persistent atrial fibrillation.</jats:p>               </jats:sec>               <jats:sec id="abs1-3">                  <jats:title>Design</jats:title>                  <jats:p>This was a prospective, multicentre, randomised control trial.</jats:p>               </jats:sec>               <jats:sec id="abs1-4">                  <jats:title>Setting</jats:title>                  <jats:p>Four NHS tertiary centres in England.</jats:p>               </jats:sec>               <jats:sec id="abs1-5">                  <jats:title>Participants</jats:title>                  <jats:p>Adults with long-standing persistent atrial fibrillation, who had European Heart Rhythm Association symptom scores > 2 and who were naive to previous catheter ablation or thoracic/cardiac surgery.</jats:p>               </jats:sec>               <jats:sec id="abs1-6">                  <jats:title>Interventions</jats:title>                  <jats:p>Minimally invasive thoracoscopic surgical ablation and conventional catheter ablation (control intervention).</jats:p>               </jats:sec>               <jats:sec id="abs1-7">                  <jats:title>Mai
AU  - Haldar,S
AU  - Khan,HR
AU  - Boyalla,V
AU  - Kralj-Hans,I
AU  - Jones,S
AU  - Lord,J
AU  - Onyimadu,O
AU  - Sathishkumar,A
AU  - Bahrami,T
AU  - Clague,J
AU  - De,Souza A
AU  - Francis,D
AU  - Hussain,W
AU  - Jarman,J
AU  - Jones,DG
AU  - Chen,Z
AU  - Mediratta,N
AU  - Hyde,J
AU  - Lewis,M
AU  - Mohiaddin,R
AU  - Salukhe,T
AU  - Murphy,C
AU  - Kelly,J
AU  - Khattar,R
AU  - Toff,WD
AU  - Markides,V
AU  - McCready,J
AU  - Gupta,D
AU  - Wong,T
DO  - 10.3310/eme08180
EP  - 122
PY  - 2021///
SN  - 2050-4365
SP  - 1
TI  - Thoracoscopic surgical ablation versus catheter ablation as first-line treatment for long-standing persistent atrial fibrillation: the CASA-AF RCT
T2  - Efficacy and Mechanism Evaluation
UR  - http://dx.doi.org/10.3310/eme08180
VL  - 8
ER  -
Download